On June 17, Merck received FDA approval for a vaccine designed to protect adults from pneumococcus, a type of bacteria that can cause serious disease, including pneumonia.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA approves 1st adult vaccine for bacterial pneumonia
